ACET FY 2023 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$76M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$152M

Net Income

-$143M

EPS (Diluted)

$-52.96

Cash Flow

Operating Cash Flow

-$94M

Free Cash Flow

-$98M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$207M

Total Liabilities

$37M

Stockholders' Equity

$170M

Cash & Equivalents

$160M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$25M	-100.0%
Gross Profit	$0	$25M	-100.0%
Operating Income	-$152M	-$73M	-109.6%
Net Income	-$143M	-$70M	-104.4%